1. Home
  2. DHY vs BTMD Comparison

DHY vs BTMD Comparison

Compare DHY & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DHY

Credit Suisse High Yield Bond Fund

HOLD

Current Price

$1.65

Market Cap

240.4M

Sector

Finance

ML Signal

HOLD

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$1.36

Market Cap

46.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHY
BTMD
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
240.4M
46.2M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
DHY
BTMD
Price
$1.65
$1.36
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$2.83
AVG Volume (30 Days)
785.4K
330.6K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
722.22
EPS
N/A
N/A
Revenue
N/A
$192,219,000.00
Revenue This Year
N/A
$2.03
Revenue Next Year
N/A
$6.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.62
$1.27
52 Week High
$2.13
$3.31

Technical Indicators

Market Signals
Indicator
DHY
BTMD
Relative Strength Index (RSI) 32.97 37.37
Support Level N/A $1.32
Resistance Level $2.05 $1.68
Average True Range (ATR) 0.02 0.11
MACD -0.01 0.00
Stochastic Oscillator 22.73 9.98

Price Performance

Historical Comparison
DHY
BTMD

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Credit Fund is a diversified, closed-end management investment company. The Fund's principal investment objective is to generate current income. Capital appreciation is a secondary objective, pursued to the extent consistent with the Fund's primary income objective.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: